Sotera Health (SHC)
undefined
undefined%
At close: undefined
13.15
0.00%
After-hours Dec 13, 2024, 04:00 PM EST

Company Description

Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally.

The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries.

It serves medical devices; pharmaceuticals; food and agricultural products; and commercial, advanced, and specialty application industries.

The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020.

Sotera Health Company was incorporated in 2017 and is headquartered in Broadview Heights, Ohio.

Sotera Health
Sotera Health logo
Country United States
IPO Date Nov 20, 2020
Industry Medical - Diagnostics & Research
Sector Healthcare
Employees 3,000
CEO Michael B. Petras Jr.

Contact Details

Address:
9100 South Hills Boulevard
Broadview Heights, Ohio
United States
Website https://soterahealth.com

Stock Details

Ticker Symbol SHC
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001822479
CUSIP Number 83601L102
ISIN Number US83601L1026
Employer ID 47-3531161
SIC Code 8090

Key Executives

Name Position
Michael B. Petras Jr. Chairman & Chief Executive Officer
Jonathan M. Lyons Senior Vice President & Chief Financial Officer
Kristin A. Gibbs Chief Marketing Officer
Robert G. Hauzie Chief Information Officer
Alexander Dimitrief J.D. Senior Vice President, General Counsel & Secretary
Danielle J. Menture Senior Vice President of Global Environmental, Health & Safety and Sustainability
Joseph A. Shrawder President of Nelson Labs
Michael P. Rutz President of Sterigenics
Sally R. Turner Chief Human Resources Officer
William O. Lehmann Jr., J.D., M.B.A. Senior Vice President of Strategy & Corporate Development

Latest SEC Filings

Date Type Title
Nov 22, 2024 4 Filing
Nov 22, 2024 4 Filing
Nov 20, 2024 8-K Current Report
Nov 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Nov 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Nov 12, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Nov 05, 2024 10-Q Quarterly Report
Nov 05, 2024 8-K Current Report
Nov 04, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Sep 13, 2024 SC 13G Statement of acquisition of beneficial ownership b...